 Prevention gram-positive infections bone marrow transplantation systemic vancomycin prospective randomized trial Gram-positive bacteria isolated organisms bone marrow transplantation BMT severe streptococcus septicemia order benefit gram-positive prophylaxis BMT prospective randomized trial systemic vancomycin patients undergoing BMT hematologic malignancies Patients receive prophylactic vancomycin mg/kg hours day resolution neutropenia first episode fever patients laminar air-flow rooms sterile diet total gut decontamination central venous catheters Vancomycin effective gram-positive infections patients control group versus vancomycin group gram-positive infections control group symptomatic septicemia local infections patient Streptococcus septicemia pneumonia gram-positive prophylaxis infection morbidity BMT number days fever empiric antibiotic therapy added toxicity cost study high prevalence gram-positive infections BMT clinical benefits adapted prophylaxis